Cargando…

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is a clinically heterogeneous disease, and treatment leads to different outcomes for people with similar diagnoses. Identifying patients who may respond to chemotherapy and thereby benefit from improved survival has important implications for treatment protocols. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muranaka, Hayato, Hendifar, Andrew, Osipov, Arsen, Moshayedi, Natalie, Placencio-Hickok, Veronica, Tatonetti, Nicholas, Stotland, Aleksandr, Parker, Sarah, Van Eyk, Jennifer, Pandol, Stephen J., Bhowmick, Neil A., Gong, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252041/ https://www.ncbi.nlm.nih.gov/pubmed/37296982 http://dx.doi.org/10.3390/cancers15113020

Ejemplares similares

Gut microbiome and pancreatic cancer cachexia: An evolving relationship
por: Hendifar, Andrew, et al.
Publicado: (2022)

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia
por: Gresham, Gillian, et al.
Publicado: (2021)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer
por: Anderson, Eric, et al.
Publicado: (2021)

Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol
por: Gong, Jun, et al.
Publicado: (2023)

Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
por: Midthun, Lauren, et al.
Publicado: (2022)

Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
por: David, John M., et al.
Publicado: (2018)

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
por: Gong, Jun, et al.
Publicado: (2019)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021)

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study
por: Gong, Jun, et al.
Publicado: (2022)

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations
por: Gong, Jun, et al.
Publicado: (2019)

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

Pancreatic cancer ‘mismatch’ in Lynch syndrome
por: Hendifar, Andrew E, et al.
Publicado: (2019)

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
por: Guan, Michelle, et al.
Publicado: (2019)

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma
por: Hendifar, Andrew, et al.
Publicado: (2016)

Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000–2018
por: Samaan, Jamil S., et al.
Publicado: (2023)

Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma
por: Lao, Yi, et al.
Publicado: (2019)

Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
por: Kim, Sungjin, et al.
Publicado: (2020)

Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
por: Lee, Patrick C., et al.
Publicado: (2021)

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
por: Tuli, R., et al.
Publicado: (2019)

Heterogeneous cancer associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
por: Kato, Manabu, et al.
Publicado: (2018)

Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth
por: Placencio, Veronica R., et al.
Publicado: (2010)

Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance
por: Haldar, Subhash, et al.
Publicado: (2020)

High-Field Asymmetric Waveform Ion Mobility Spectrometry: Practical Alternative for Cardiac Proteome Sample Processing
por: Ai, Lizhuo, et al.
Publicado: (2023)

Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
por: Gong, Jun, et al.
Publicado: (2022)

Pancreatic cancer cachexia: a review of mechanisms and therapeutics
por: Tan, Carlyn R., et al.
Publicado: (2014)

Su1077: PANCREATIC CANCER (PC) MORTALITY RATES ARE DECREASING IN YOUNG MEN BUT NOT YOUNG WOMEN IN THE US, 2000 – 2019: A POPULATION-BASED TIME-TREND ANALYSIS USING THE CDC'S NATIONAL CENTER OF HEALTH STATISTICS (NCHS) DATABASE
por: Abboud, Yazan, et al.
Publicado: (2022)

Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma
por: Wang, Nan, et al.
Publicado: (2023)

Meta-analyses of treatment standards for pancreatic cancer
por: GONG, JUN, et al.
Publicado: (2016)

POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
por: Bikhchandani, Mihir, et al.
Publicado: (2023)

MitoTimer: a novel protein for monitoring mitochondrial turnover in the heart
por: Gottlieb, Roberta A., et al.
Publicado: (2014)

α-MHC MitoTimer mouse: In vivo mitochondrial turnover model reveals remarkable mitochondrial heterogeneity in the heart
por: Stotland, Aleksandr, et al.
Publicado: (2015)

Uniting Epidemiology and Experimental Models: Pancreatic Steatosis and Pancreatic Cancer
por: Truong, Emily, et al.
Publicado: (2022)

Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data
por: Baecker, Aileen, et al.
Publicado: (2019)

Uniting Epidemiology and Experimental Disease Models for Alcohol-Related Pancreatic Disease
por: Setiawan, Veronica Wendy, et al.
Publicado: (2017)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner
por: Zhang, Le, et al.
Publicado: (2022)

Multiparametric Mapping Magnetic Resonance Imaging of Pancreatic Disease
por: Wang, Lixia, et al.
Publicado: (2020)

Diabetes, pancreatic cancer, and metformin therapy
por: Gong, Jun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kt1vtbmjeqqc197m8mntitmloo